OncoFirm™ CEA
Rapid Lateral Flow Immunoassay for Carcinoembryonic Antigen (CEA) Investigational device in the United States. OncoFirm™ CEA has not been cleared or approved by the U.S. Food and Drug Administration and…
-
-
OncoFirm™ PSA
Rapid Lateral Flow Immunoassay for Total Prostate-Specific Antigen (PSA) Investigational device in the United States. OncoFirm™ PSA has not been cleared or approved by the U.S. Food and Drug Administration…
-
OncoFirm™MultiDx
Investigational Multiplex Lateral Flow Assay for Cancer-Associated Biomarkers Investigational device. OncoFirm™ MultiDx is in development and has not been cleared or approved by the U.S. Food and Drug Administration or…
-
OncoFirm™-B: Investigational TF / Gal-GalNAc Assay for Breast and Ovarian Cancer Research
OncoFirm™-B is a concept-stage, investigational lateral flow assay for TF / Gal-GalNAc antigen in breast and ovarian cancer research. Not FDA cleared.
